These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37596597)

  • 1. m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia.
    Fu C; Kou R; Meng J; Jiang D; Zhong R; Dong M
    BMC Med Genomics; 2023 Aug; 16(1):191. PubMed ID: 37596597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of an acute myeloid leukemia prognostic model based on m6A-related efferocytosis-related genes.
    Wang Y; Bin T; Tang J; Xu XJ; Lin C; Lu B; Sun TT
    Front Immunol; 2023; 14():1268090. PubMed ID: 38077322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid Leukemia.
    Wang J; Zhuo Z; Wang Y; Yang S; Chen J; Wang Y; Geng S; Li M; Du X; Lai P; Weng J
    Front Cell Dev Biol; 2021; 9():800267. PubMed ID: 35127715
    [No Abstract]   [Full Text] [Related]  

  • 4. N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia.
    Zhang L; Ke W; Hu P; Li Z; Geng W; Guo Y; Song B; Jiang H; Zhang X; Wan C
    Front Genet; 2022; 13():804614. PubMed ID: 35615374
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of m6A-Related lncRNAs Associated With Prognoses and Immune Responses in Acute Myeloid Leukemia.
    Li D; Liang J; Cheng C; Guo W; Li S; Song W; Song Z; Bai Y; Zhang Y; Wu X; Zhang W
    Front Cell Dev Biol; 2021; 9():770451. PubMed ID: 34869365
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of m6A-related signatures associated with the tumor immune microenvironment and predict survival in acute myeloid leukemia.
    Yuan S; Cong Z; Ji J; Zhu L; Jiang Q; Zhou Y; Shen Q; Damiani D; Xu X; Li B
    Ann Transl Med; 2022 Aug; 10(16):902. PubMed ID: 36111007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of N6-Methyladenosine-Related Long Noncoding RNA Prognosis of Acute Myeloid Leukemia and Immune Cell Infiltration.
    Zheng G; Liu M; Chang X; Cao X; Dong A; Zhu H; Hu W; Xie J; Zhao Y; Hu D; Jia X; Yang Y; Shi X; Lu J
    Front Genet; 2022; 13():888173. PubMed ID: 35601490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma.
    Chen D; Guo W; Yu H; Yang J
    Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia.
    Li P; Li J; Wen F; Cao Y; Luo Z; Zuo J; Wu F; Li Z; Li W; Wang F
    Front Oncol; 2022; 12():966920. PubMed ID: 36276132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma.
    Lin W; Tan ZY; Fang XC
    SLAS Technol; 2024 Feb; 29(1):100101. PubMed ID: 37541541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
    BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y; Qu H
    BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Analysis of Autophagy-Related Signature Uncovers Prognostic Predictor for Acute Myeloid Leukemia.
    Chen XX; Li ZP; Zhu JH; Xia HT; Zhou H
    DNA Cell Biol; 2020 Sep; 39(9):1595-1605. PubMed ID: 32783661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Metabolism-Related Gene Signature Predicts the Survival of Patients with Acute Myeloid Leukemia.
    Zhai Y; Shen H; Wei H
    Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
    Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification and validation of an m6A-related gene signature to predict prognosis and evaluate immune features of breast cancer.
    Li W; Wang X; Li C; Chen T; Zhou X; Li Z; Yang Q
    Hum Cell; 2023 Jan; 36(1):393-408. PubMed ID: 36403174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.